Santra et al., 2020 - Google Patents
Single-cell analysisSantra et al., 2020
View HTML- Document ID
- 1417741294671598229
- Author
- Santra T
- Tseng F
- Publication year
- Publication venue
- Cells
External Links
Snippet
Cells are known to be the most fundamental building block of life. Cells form our bodies grow, reproduce, process information, and they can respond to the stimuli and process different chemical reactions [1]. However, to date, the interactions between cells, the …
- 238000004458 analytical method 0 title abstract description 61
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kaushik et al. | Point of care sensing devices: better care for everyone | |
Emmert-Streib et al. | A machine learning perspective on Personalized Medicine: an automized, comprehensive knowledge base with ontology for pattern recognition | |
Akgönüllü et al. | Microfluidic systems for cancer diagnosis and applications | |
Grimm | Current knowledge in thyroid cancer—From bench to bedside | |
Bulbul et al. | Nanopipettes as monitoring probes for the single living cell: state of the art and future directions in molecular biology | |
Mahmoudi et al. | iMethyl-Deep: N6 methyladenosine identification of yeast genome with automatic feature extraction technique by using deep learning algorithm | |
Santra et al. | Single-cell analysis | |
Cerchia | Aptamers: promising tools for cancer diagnosis and therapy | |
Yanagisawa et al. | Convolutional neural network can recognize drug resistance of single cancer cells | |
Güven et al. | Screening the significant hub genes by comparing tumor cells, normoxic and hypoxic glioblastoma stem-like cell lines using Co-expression analysis in glioblastoma | |
Pillai et al. | Mapping the potential of microfluidics in early diagnosis and personalized treatment of head and neck cancers | |
Sicherre et al. | Non-specific binding, a limitation of the immunofluorescence method to study macrophages in situ | |
Fang et al. | Digital PCR for single-cell analysis | |
Li et al. | Microfluidic based organ-on-chips and biomedical application | |
Binder et al. | Modelling and differential quantification of electric cell-substrate impedance sensing growth curves | |
Bindayna | MicroRNA as sepsis biomarkers: A comprehensive review | |
Yamamura et al. | Separation and analysis of adherent and non-adherent cancer cells using a single-cell microarray chip | |
Majumder et al. | Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen–Fibrin Gels by Cytolytic and Non-Lytic Mechanisms | |
Ulivi et al. | Liquid biopsies in cancer diagnosis, monitoring and prognosis | |
Bist et al. | Screening genotoxicity chemistry with microfluidic electrochemiluminescent arrays | |
Papadaki et al. | Single-cell RNA sequencing uncovers heterogeneous circulating tumor cell subsets in breast cancer | |
Potts et al. | Discordant genome assemblies drastically alter the interpretation of single-cell RNA sequencing data which can be mitigated by a novel integration method | |
Carpenter et al. | Clinical functional genomics | |
Gromiha et al. | From code to cure: the impact of artificial intelligence in biomedical applications | |
Nance et al. | Single-nuclei multiome (ATAC+ Gene Expression) sequencing of a primary canine osteosarcoma elucidates intra-tumoral heterogeneity and characterizes the tumor microenvironment |